Labs

DeBiasi Laboratory

About the Lab

Roberta DeBiasi's, MD, MS, research expertise includes basic science and clinical/translational research. She serves as principal investigator for research and clinical trials focusing on severe and emerging infections affecting normal children, immunocompromised hosts, neonates and pregnant women. Specific areas of research focus include: NIAID/NIH Congenital and Perinatal Infection Consortium funding to study natural history and novel treatments for congenital cytomegalovirus infection, neonatal herpes simplex virus, enterovirus and parechovirus infection. She co-directs the Congenital Infection Program at Children's National Hospital, which includes research protocols in the U.S. and internationally focused on prenatal imaging, testing, genetics and virologic aspects of congenital infection. Her research portfolio includes studies focused on treatment and long-term outcomes of Lyme disease and COVID infection in children, as well as Kawasaki Disease. She is also involved in emergency investigational new drug (IND) acquisition of agents for the treatment of severe viral myocarditis, encephalitis and malaria.

  • Lab Focus Areas

    Congenital viral infection

    Emerging infectious diseases

    Lyme and tick-borne disease


  • Partnerships

    Infectious Diseases Division

    NIH Congenital and Perinatal Infection Consortium

    NIAID-CNH Research Partnership

    Lyme Clinical Trials Network

  • Contact

    Roberta DeBiasi, MD, MS Chief, Division of Pediatric Infectious Diseases, Robert H. Parrot Professor of Pediatric Research